1
|
Campos CDM, Gamage SST, Jackson JM, Witek MA, Park DS, Murphy MC, Godwin AK, Soper SA. Microfluidic-based solid phase extraction of cell free DNA. LAB ON A CHIP 2018; 18:3459-3470. [PMID: 30339164 PMCID: PMC6391159 DOI: 10.1039/c8lc00716k] [Citation(s) in RCA: 39] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/20/2023]
Abstract
Cell-free DNA (cfDNA) is a liquid biopsy marker that can carry signatures (i.e., mutations) associated with certain pathological conditions. Therefore, the extraction of cfDNA from a variety of clinical samples can be an effective and minimally invasive source of markers for disease detection and subsequent management. In the oncological diseases, circulating tumor DNA (ctDNA), a cfDNA sub-class, can carry clinically actionable mutations and coupled with next generation sequencing or other mutation detection methods provide a venue for effective in vitro diagnostics. However, cfDNA mutational analyses require high quality inputs. This necessitates extraction platforms that provide high recovery over the entire ctDNA size range (50 → 150 bp) with minimal interferences (i.e., co-extraction of genomic DNA), and high reproducibility with a simple workflow. Herein, we present a novel microfluidic solid-phase extraction device (μSPE) consisting of a plastic chip that is activated with UV/O3 to generate surface-confined carboxylic acid functionalities for the μSPE of cfDNA. The μSPE uses an immobilization buffer (IB) consisting of polyethylene glycol and salts that induce cfDNA condensation onto the activated plastic microfluidic surface. The μSPE consists of an array of micropillars to increase extraction bed load (scalable to loads >700 ng of cfDNA) and can be produced at low-cost using replication-based techniques. The entire μSPE can be fabricated in a single molding step negating the need for adding additional extraction supports to the device simplifying production and keeping device and assay cost low. The μSPE allowed for recoveries >90% of model cfDNA fragments across a range of sizes (100-700 bp) and even the ability to extract efficiently short cfDNA fragments (50 bp, >70%). In addition, the composition of the IB allowed for reducing the interference of co-extracted genomic DNA. We demonstrated the clinical utility of the μSPE by quantifying the levels of cfDNA in healthy donors and patients with non-small-cell lung and colorectal cancers. μSPE extracted cfDNA from plasma samples was also subjected to a ligase detection reaction (LDR) for determining the presence of mutations in the KRAS gene for colorectal and non-small cell lung cancer patients.
Collapse
Affiliation(s)
- Camila D. M. Campos
- Department of Chemistry, University of Kansas, Lawrence, KS, USA.
- Center of Biomodular Multi-scale Systems for Precision Medicine, USA
| | - Sachindra S. T. Gamage
- Department of Chemistry, University of Kansas, Lawrence, KS, USA.
- Center of Biomodular Multi-scale Systems for Precision Medicine, USA
| | - Joshua M. Jackson
- Department of Chemistry, University of Kansas, Lawrence, KS, USA.
- Center of Biomodular Multi-scale Systems for Precision Medicine, USA
| | - Malgorzata A. Witek
- Department of Chemistry, University of Kansas, Lawrence, KS, USA.
- Center of Biomodular Multi-scale Systems for Precision Medicine, USA
- Department of Biomedical Engineering, The University of North Carolina, Chapel Hill, NC 27599, USA
| | - Daniel S. Park
- Center of Biomodular Multi-scale Systems for Precision Medicine, USA
- Department of Mechanical Engineering, Louisiana State University, Baton Rouge, LA, USA
| | - Michael C. Murphy
- Center of Biomodular Multi-scale Systems for Precision Medicine, USA
- Department of Mechanical Engineering, Louisiana State University, Baton Rouge, LA, USA
| | - Andrew K. Godwin
- University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, KS, USA
| | - Steven A. Soper
- Department of Chemistry, University of Kansas, Lawrence, KS, USA.
- Center of Biomodular Multi-scale Systems for Precision Medicine, USA
- University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, KS, USA
- BioEngineering Program, The University of Kansas, Lawrence, KS 66047, USA
- Department of Mechanical Engineering, The University of Kansas, Lawrence, KS 66047, USA
- Ulsan National Institute of Science and Technology, Ulsan, Republic of Korea
| |
Collapse
|